Biosensors and Nanotheranostics
Bionanotechnology, Drug Delivery, Therapeutics | online ISSN 3064-7789
175
Citations
127.8k
Views
108
Articles
REVIEWS (Open Access)
Physicochemical Properties, Drug Loading, and Release Kinetics of PLGA and PLGA-PEG Systems: A Systematic Review
Tufael 1*, Gurudutta Pattnaik 2, Amged Gaffer Mostafa Gaffer 3, Sameh Elsonbaty 3
Biosensors and Nanotheranostics 4 (1) 1-8 https://doi.org/10.25163/biosensors.4110515
Submitted: 12 October 2025 Revised: 11 December 2025 Accepted: 17 December 2025 Published: 18 December 2025
Abstract
Poly(lactic-co-glycolic acid) (PLGA) nanoparticles have emerged as a versatile platform for controlled drug delivery. The incorporation of polyethylene glycol (PEG) into PLGA-based systems has been widely explored to enhance stability, drug encapsulation, and release kinetics. This systematic review and meta-analysis evaluated multiple studies on PLGA-PEG formulations encapsulating proteins, antibiotics, and hydrophobic drugs, examining their physicochemical characteristics, entrapment efficiency, loading capacity, and in vitro release profiles. Data synthesis revealed that PEGylation generally reduces particle size, improves homogeneity, and enhances encapsulation efficiency compared to conventional PLGA nanoparticles. Meta-analytic pooling indicated that PEG content and molecular weight significantly influence release kinetics, with higher PEG fractions promoting sustained, controlled release. Lysozyme-loaded formulations demonstrated variable degradation-dependent release profiles, while small-molecule drugs such as Trimethoprim and Simvastatin showed rapid initial release followed by slower, diffusion-driven kinetics. Statistical analysis confirmed that polymer composition and PEG content are critical determinants of nanoparticle performance. Funnel and forest plot assessments suggested low-to-moderate publication bias, reinforcing the reliability of the aggregated findings. Overall, PEGylated PLGA nanoparticles consistently exhibited improved drug delivery performance, underscoring their potential for therapeutic applications. These results provide a comprehensive reference for rational design of polymeric nanoparticles tailored to specific drug types and clinical objectives.Keywords: PLGA, PEGylation, nanoparticles, drug delivery, encapsulation efficiency, controlled release, systematic review, meta-analysis
References
Agrawal, S. K., Sanabria-DeLong, N., Coburn, J. M., Tew, G. N., & Bhatia, S. R. (2006). Novel drug release profiles from micellar solutions of PLA-PEG-PLA triblock copolymers. Journal of Controlled Release, 112(1), 64–71.
Ainurofiq, A., & Choiri, S. (2018). Development and optimization of a meloxicam/beta-cyclodextrin complex for orally disintegrating tablet using statistical analysis. Pharmaceutical Development and Technology, 23(5), 464–475. doi:10.1080/10837450.2016.1264418
Ainurofiq, A., Choiri, S., Azhari, M. A., Siagian, C. R., Suryadi, B. B., & Prihapsara, F. (2016). Improvement of meloxicam solubility using a beta-cyclodextrin complex prepared via the kneading method and incorporated into an orally disintegrating tablet. Advanced Pharmaceutical Bulletin, 6(3), 399–406. doi:10.15171/apb.2016.052
Alemdar, A., Güngör, N., Ece, O. I., & Atici, O. I. (2005). The rheological properties and characterization of bentonite dispersions in the presence of non-ionic polymer PEG. Journal of Materials Science, 40(17), 4485–4491. doi:10.1007/s10853-005-5703-4
Alavi, S. E., Bakht, U., Koohi Moftakhari Esfahani, M., Adelnia, H., Abdollahi, S. H., Ebrahimi Shahmabadi, H., & Raza, A. (2022). A PEGylated nanostructured lipid carrier for enhanced oral delivery of antibiotics. Pharmaceutics, 14(8), 1668. doi:10.3390/pharmaceutics14081668
Allen, T. M., & Cullis, P. R. (2004). Drug delivery systems: entering the mainstream. Science, 303(5665), 1818–1822. doi:10.1126/science.1095833
Almoustafa, H. A., Alshawsh, M. A., & Chik, Z. (2017). Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic agents by nanoprecipitation method. International Journal of Pharmaceutics, 533(1), 275–284. doi:10.1016/j.ijpharm.2017.09.054
Anderson, J. M., & Shive, M. S. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews, 28(1), 5–24. doi:10.1016/S0169-409X(97)00048-3
Bernstein, H., Zhang, Y., Khan, A. M., & Tracy, M. A. (1997). Modulated release from biodegradable polymers (U.S. Patent No. 5,656,297).
Bianchini, G., Balko, J. M., Mayer, I. A., & Sanders, M. E. (2016). Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nature Reviews Clinical Oncology, 13(11), 674–690. doi:10.1038/nrclinonc.2016.100
Bittner, B., Witt, C., Mäder, K., & Kissel, T. (1999). Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release. Journal of Controlled Release, 60(2–3), 297–309. doi:10.1016/S0168-3659(99)00078-4
Blanco-Prieto, M. J., Besseghir, K., Zerbe, O., Andris, D., Orsolini, P., Gander, B., & Doelker, E. (2000). In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres. Journal of Controlled Release, 67(1), 19–28. doi:10.1016/S0168-3659(00)00201-9
Bodro, M., & Paterson, D. L. (2013). Has the time come for routine trimethoprim-sulfamethoxazole prophylaxis in patients taking biologic therapies? Clinical Infectious Diseases, 56(12), 1621–1628. doi:10.1093/cid/cit125
Bosch, A., Eroles, P., Zaragoza, R., Viña, J. R., & Lluch, A. (2010). Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research. Cancer Treatment Reviews, 36(3), 209–215. doi:10.1016/j.ctrv.2009.12.002
Brauner, B., Schwarz, P., Wirth, M., & Gabor, F. (2020). Micro vs. nano: PLGA particles loaded with trimethoprim for instillative treatment of urinary tract infections. International Journal of Pharmaceutics, 579, 119158. doi:10.1016/j.ijpharm.2020.119158
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. doi:10.3322/caac.21492
Brostow, W., Chiu, R., Kalogeras, I. M., & Vassilikou-Dova, A. (2008). Prediction of glass transition temperatures: binary blends and copolymers. Materials Letters, 62(17–18), 3152–3155. doi:10.1016/j.matlet.2008.02.008
Brouwers, J., Brewster, M. E., & Augustijns, P. (2009). Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? Journal of Pharmaceutical Sciences, 98(8), 2549–2572. doi:10.1002/jps.21650
Bruschi, M. L. (2015). Strategies to modify the drug release from pharmaceutical systems. Elsevier.
Bursch, W., Török, I., & Heastman, E. (2000). Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. Journal of Cell Science, 113(7), 1189–1198.
Cantley, L. C. (2002). The phosphoinositide 3-kinase pathway. Science, 296(5573), 1655–1657. doi:10.1126/science.296.5573.1655
Cardoso, M. M., Peça, I. N., & Bicho, A. (2024). Impact of PEG content on doxorubicin release from PLGA-co-PEG nanoparticles. Materials, 17(16), 3544. doi:10.3390/ma17163544
Chan, P. S., Xian, J. W., Li, Q., Chan, C. W., Leung, S. S. Y., & To, K. K. W. (2019). Biodegradable thermosensitive PLGA-PEG-PLGA polymer for non-irritating and sustained ophthalmic drug delivery. AAPS Journal, 21(4), 59. doi:10.1208/s12248-019-0326-x
Chanthavong, V., Vigad, N., Pelyuntha, W., Yamik, D. Y., Vongkamjan, K., Yingkajorn, M., ... & Chukiatsiri, K. (2025). Effectiveness of a single-dose phage cocktail on the reduction of multidrug-resistant Escherichia coli in suckling piglets. Veterinary Microbiology, 302, 110395. doi:10.1016/j.vetmic.2024.110395
Charlier, A., Leclerc, B., & Couarraze, G. (2000). Release of mifepristone from biodegradable matrices: experimental and theoretical evaluations. International Journal of Pharmaceutics, 200(1–2), 115–120. doi:10.1016/S0378-5173(00)00371-X
Chen, X., Chen, J., Li, B., Yang, X., Zeng, R., Liu, Y., & Wei, X. (2017). PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: in vitro drug release and in vivo pharmacokinetics assessment. Journal of Colloid and Interface Science, 490, 542–552. doi:10.1016/j.jcis.2016.11.089
Chiappetta, D. A., & Sosnik, A. (2007). Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. European Journal of Pharmaceutics and Biopharmaceutics, 66(3), 303–317. doi:10.1016/j.ejpb.2007.03.022
Chiba, M., Hanes, J., & Langer, R. (1997). Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres. Biomaterials, 18(13), 893–901. doi:10.1016/S0142-9612(97)00028-2
Chieng, B., Ibrahim, N. A., Yunus, W. M. Z. W., & Hussein, M. Z. (2014). Poly(lactic acid)/poly(ethylene glycol) polymer nanocomposites: effects of graphene nanoplatelets. Polymers, 6(1), 93–104. doi:10.3390/polym6010093
Costa, M. S., Ramos, A. M., & Cardoso, M. M. (2025). Drug release kinetics of PLGA-PEG microspheres encapsulating aclacinomycin A: the influence of PEG content. Processes, 13(1), 112. doi:10.3390/pr13010112
Cui, C., Stevens, V. C., & Schwendeman, S. P. (2007). Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine. Vaccine, 25(3), 500–509. doi:10.1016/j.vaccine.2006.08.026
Dabholkar, R. D., Sawant, R. M., Mongayt, D. A., Devarajan, P. V., & Torchilin, V. P. (2006). Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. International Journal of Pharmaceutics, 315(1–2), 148–157. doi:10.1016/j.ijpharm.2006.02.018
Dahlan, R., McDonald, C., & Sunderland, V. B. (1987). Solubilities and intrinsic dissolution rates of sulphamethoxazole and trimethoprim. Journal of Pharmacy and Pharmacology, 39(4), 246–251. doi:10.1111/j.2042-7158.1987.tb03113.x
Dash, S., Murthy, P. N., Nath, L., & Chowdhury, P. (2010). Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharmaceutica — Drug Research, 67(3), 217–223.
Danyuo, Y., Obayemi, J. D., & Soboyejo, W. O. (2014). Prodigiosin release from an implantable biomedical device: kinetics of localized cancer drug release. Materials Science and Engineering: C, 44, 251–258. doi:10.1016/j.msec.2014.06.008
Danyuo, Y., Obayemi, J. D., Moryl, J., Zhang, Z., Odesanya, O. S., Nwogbo, B. C., & Soboyejo, W. O. (2019). Anomalous release kinetics of prodigiosin from poly-N-isopropyl-acrylamide-based hydrogels for the treatment of triple negative breast cancer. Scientific Reports, 9(1), 2568. doi:10.1038/s41598-019-39578-4
Dave, S. R., & Gao, X. (2009). Monodisperse magnetic nanoparticles for biodetection, imaging, and drug delivery: a versatile and evolving technology. WIREs Nanomedicine and Nanobiotechnology, 1(6), 583–609. doi:10.1002/wnan.60
De Laurentiis, L., Tagliaferri, P., & Rotella, V. (2010). Treatment of triple negative breast cancer (TNBC): current options and future perspectives. Cancer Treatment Reviews, 36(Suppl. 1), S47–S54. doi:10.1016/S0305-7372(10)70025-6
De Souza, L. E., Eckenstaler, R., Syrowatka, F., Beck-Broichsitter, M., Benndorf, R. A., & Mäder, K. (2021). Has PEG-PLGA advantages for the delivery of hydrophobic drugs? Risperidone as an example. Journal of Drug Delivery Science and Technology, 61, 102239. doi:10.1016/j.jddst.2020.102239
Deepika, M. S., Thangam, R., Sundarraj, S., Sheena, T. S., Sivasubramanian, S., Kulandaivel, J., & Thirumurugan, R. (2020). Co-delivery of diverse therapeutic compounds using PEG–PLGA nanoparticle cargo against drug-resistant bacteria: an improved anti-biofilm strategy. ACS Applied Bio Materials, 3(1), 385–399. doi:10.1021/acsabm.9b00989
Recommended articles
Nanotheranostics for Overcoming Tumor Heterogeneity and Drug Resistance in Solid Tumors: Imaging-Guided Therapy, Clinical Progress, and Future Directions
Bacterial Cellulose Nanocomposite Dressings Loaded with Antimicrobial Nanoparticles for Diabetic Foot Ulcers: Fabrication, Mechanisms, and Preclinical Evidence
Ubiquitin-Proteasome Dysfunction in Huntington's Disease and Its Mechanistic Insights and Druggable Targets Across the Proteostasis Network
Article metrics
View details
0
Downloads
0
Citations
18
Views
0
Save
Save
0
Citation
Citation
18
View
View
0
Share
Share